Actualizaciones en la gestión de farmacias

Humana strives to make the prescription process as simple as possible for physicians, other health care providers and members. Some prescriptions, however, require more attention than others.

The Humana Clinical Pharmacy Review (HCPR) team oversees step therapy and handles requests related to prior authorization and overriding dispensing limits. The team operates Monday-Friday, 8 a.m. to 9 p.m. EST.

Autorizaciones previas
Algunos medicamentos deben atravesar un proceso de aprobación basado en criterios, previo a una decisión de cobertura. If you need to obtain prior authorization for a prescription, you can use one of the following methods:

1) Submit your request online with Humana’s Web tool.
2) Call HCPR at 1-800-555-CLIN (2546), Monday-Friday, 8 a.m. - 9 p.m. EST. When calling in a request, be prepared with the following information:

• Patient demographic information
• Drug being requested
• Patient diagnosis
• Any drug allergies or medical conditions
• Other therapies or procedures attempted
• Desired length of therapy

Most requests for authorization require appropriate lab information before they can be processed.

3) Fax the form to HCPR at 1-877-486-2621. Fax forms can be downloaded online through the following process:

• Go to the “Provider” area of Humana.com
• Under “Quick Links,” choose “Prescription Tools”
• Scroll down to the “Prior Authorization” link

You can also view a list of drugs that require prior authorization by clicking on “Humana’s Drug List” on the same page as the “Prior Authorization” link.

CMS Definition of a Part D Drug
A prescription drug is a Part D drug only if it is prescribed for a medically accepted indication as defined by Medicare statute. This definition includes uses that are approved by the Federal Drug Administration (FDA) or supported by a citation included, or approved for inclusion, in one of the following compendia:

  • American Hospital Formulary Service Drug Information
  • United States Pharmacopeia-Drug Information
  • DRUGDEX Information System

Based on this statutory definition, indications that are supported in peer-reviewed medical literature that have not yet been approved by the FDA or reflected in one of the compendia are not medically accepted. Therefore, the use of a drug for such indications would not meet the definition of a Part D drug and is not payable under the Medicare Part D benefit.

Límites máximos de venta
Maximum dispensing limits are based on product information approved by the FDA and recommendations from the drug’s manufacturer. These limits are reviewed and approved by Humana’s Pharmacy and Therapeutics Committee, which is composed of both pharmacists and physicians.

If a patient’s medical condition warrants additional quantities, call HCPR at
1-800-555-CLIN (2546), Monday-Friday, 8 a.m.-9 p.m. EST. You should be prepared with the same information as for a prior authorization request (see list at left). For a list of drugs with a dispensing limit, take the following steps:

• Go to the “Provider” area of Humana.com
• Under “Quick Links,” choose “Prescription Tools”
• Choose “Humana’s Drug List”
• Click on the link under “Quantity Limit” under “Updates”

Terapia escalonada
The Medicare Prescription Drug Plan is subject to step therapy protocols. Step therapy protocols require patients to utilize medications commonly considered first-line before using medications considered second-line or third-line. Estos protocolos se utilizan para promover pautas de tratamiento nacionales establecidas. Además, los protocolos de terapia escalonada contribuyen a la promoción de terapias con medicamentos seguros y accesibles.

Some drugs are restricted to a particular gender and/or age group for coverage. This is based on how the drug is to be used and the subpopulation the drug is intended to treat.
If you have questions about a step therapy regimen, call HCPR at 1-800-555-CLIN (2546), Monday-Friday, 8 a.m.-9 p.m. EST.

Excepción y rechazo de solicitudes
For an exception to a Medicare Part D drug management tool, call HCPR at
1-800-555-CLIN (2546), Monday-Friday,
8 a.m.-9 p.m. EST.

For information about Exception and Appeals, take the following steps:

• Go to the “Provider” area of Humana.com
• Under “Quick Links,” choose “Prescription Tools”
• Scroll down to the “Exception and Appeals” link

Generally, HCPR will give providers a decision within 72 hours of receiving their supporting statement for authorization. Providers can request an expedited review if the standard response time would cause serious harm or endanger a member’s health. HCPR will make the decision within 24 hours if the patient’s medical condition requires it.

Humana wants physicians to know that the following brand-name drugs are now available generically:

Zocor
Pravachol
Norvasc
Coreg
Altace
Mavik
Toprol XL
Ambien

Zoloft
Fosamax
Ditropan XL
Mobic
Proscar
Flonase
Requip
Risperdal

Volver arriba

 

 

 

 

 

 

 

 

 

 

 



Carta de Bruce Perkins
Actualizaciones de políticas de cobertura, Webinars
  y presentaciones
Hedis® Changes for 2009
Clinical Trials, Category B Investigational Device
   Exemptions (IDEs) and Medicare Studies

Importance of Proper Signatures for CMS Data
   Validation

New Survey to Improve Provider Service
Actualizaciones en la gestión de farmacias
Arterial Venous Fistulas (AVF):
   The Gold Standard for Vascular Access
Humana Offers Resources for Caregivers and
   Advance Care Planning
Humana se compromete a mejorar la calidad
Consejos clínicos para proveedores
Faster Service with Claims Update
Safeguarding Humana Members
Pregunte a los expertos
Board Members Needed